Suzetrigine mechanism for pain relief (WP5558)

Homo sapiens

Open in new tab Open in Newt (SBGN)
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads

Suzetrigine (trade name Journavx) is an oral medication used to manage moderate to severe acute pain. It is a non-opioid, small-molecule analgesic that functions by selectively inhibiting Nav1.8-dependent pain signaling pathways in the peripheral nervous system. Unlike opioids, suzetrigine is non-addictive. Inspired by Figure 2 in Cho et al. (2025).

For a description of pathway objects, see the WikiPathways Legend.

Authors

Eric Weitz , Egon Willighagen , and Kristina Hanspers

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Cell Type Ontology

pain receptor cell peripheral sensory neuron sensory neuron of dorsal root ganglion

Pathway Ontology

drug pathway

Participants
Query Drugst.One

Label Type Compact URI Comment
Na⁺ Metabolite chebi:29101
Suzetrigine Metabolite drugbank:DB18927
SCN10A GeneProduct ensembl:ENSG00000185313

References

  1. Suzetrigine for moderate to severe acute pain. Cho EB, Jiang C, Wang Z, Yu Y, Jiang J. Trends Pharmacol Sci. 2025 May;46(5):480–1. PubMed Europe PMC Scholia